GH

NASDAQ 已收盘

Guardant Health

145.59 USD
▲+0.45+0.31%
盘后 145.60 +0.01%
2026-11-19
市值
$19.72B
市盈率
—
EPS
-3.68
股息率
—
52 周区间
74.55 – 191.05
成交量
1.87M
Beta
1.66
目标价
200.76
52W 低 74.5552W 高 191.05
价格走势

公司简介

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company offers Guardant360 CDx test, a liquid biopsy test for tumor mutation profiling; Guardant360 Liquid test, which measures 740+ genes and supports all guideline-recommended biomarkers; Guardant Reveal test, a blood test that utilizes circulating tumor DNA to detect cancer at the molecular level; and Guardant360 Tissue test, a molecular profiling test for tumor tissue that provides genomic, transc...

关联新闻